comparemela.com

Latest Breaking News On - Prnewswire projenx inc - Page 1 : comparemela.com

ProJenX Announces Formation of Scientific Advisory Board

/PRNewswire/ ProJenX, Inc., a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for.

Neil shneiderClaire henchcliffeErin flemingJoe lewcockLee rubinPhd harvard universityPhd columbia universityResearch development at projenNeuroscience programHarvard stem cell instituteColumbia universityRegenerative biology at harvard universityPrnewswire projenx incScientific advisory boardDenali therapeuticsHarvard university

ProJenX Names Life Sciences Industry Veteran Stan E Abel as CEO

Company on track for first clinical data for oral, brain-penetrant ALS drug candidate, prosetin, later this yearPhase 2/3 study initiation expecte.

Stan abelErin flemingDavid schullEli lillyStane abelEric heilPeninsula pharmaceuticals incIndiana universityCerexa incUniversity of chicago booth school businessSiteone therapeutics incColumbia universityDowbrands incPrnewswire projenx incCorthera incJenx inc

vimarsana © 2020. All Rights Reserved.